A pilot study to assess the pharmacokinetics, pharmacodynamics and safety/tolerability of pramlintide acetate when administered by subcutaneous infusion in a basal-bolus manner as an adjunct to continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes

Trial Profile

A pilot study to assess the pharmacokinetics, pharmacodynamics and safety/tolerability of pramlintide acetate when administered by subcutaneous infusion in a basal-bolus manner as an adjunct to continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Jan 2013

At a glance

  • Drugs Pramlintide (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacokinetics
  • Most Recent Events

    • 23 Jan 2008 The expected completion date for this trial is now 1 Jan 2008.
    • 15 Jan 2008 Status changed from recruiting to completed.
    • 16 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top